Since CKD is being viewed as an aging model, our hypothesis is that tissue SIRT1 level is reduced in the liver when CKD develops, and subsequently disrupts the expression of PPARα, PGC1α, FXR, LXR, and FOXO, increase the expression of SREBPs, and eventually result in altered lipids profiles. This evidence concerns the gene PPARA and chronic kidney disease.